Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge.

Erritzoe D, Ashok AH, Searle GE, Colasanti A, Turton S, Lewis Y, Huiban M, Moz S, Passchier J, Saleem A, Beaver J, Lingford-Hughes A, Nutt DJ, Howes OD, Gunn RN, Knudsen GM, Rabiner EA.

Neuropsychopharmacology. 2019 Nov 12. doi: 10.1038/s41386-019-0567-5. [Epub ahead of print]

PMID:
31715617
2.

Reduced mu opioid receptor availability in schizophrenia revealed with [11C]-carfentanil positron emission tomographic Imaging.

Ashok AH, Myers J, Reis Marques T, Rabiner EA, Howes OD.

Nat Commun. 2019 Oct 3;10(1):4493. doi: 10.1038/s41467-019-12366-4.

3.

Early motor resonance differentiates schizophrenia patients from healthy subjects and predicts social cognition performance.

Mehta UM, Ashok AH, Thirthalli J, Keshavan MS.

Prog Brain Res. 2019;247:353-374. doi: 10.1016/bs.pbr.2019.03.011. Epub 2019 Mar 28.

PMID:
31196441
4.

Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies.

Ashok AH, Mizuno Y, Howes OD.

Psychopharmacology (Berl). 2019 Apr;236(4):1119-1129. doi: 10.1007/s00213-019-05196-1. Epub 2019 Mar 18. Review.

5.

Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies.

Marques TR, Ashok AH, Pillinger T, Veronese M, Turkheimer FE, Dazzan P, Sommer IEC, Howes OD.

Psychol Med. 2019 Oct;49(13):2186-2196. doi: 10.1017/S0033291718003057. Epub 2018 Oct 25.

6.

Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.

Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M, Wang Y, Cervenka S.

Biol Psychiatry. 2018 Sep 15;84(6):433-442. doi: 10.1016/j.biopsych.2018.02.1171. Epub 2018 Mar 6.

7.

The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders.

Kokkinou M, Ashok AH, Howes OD.

Mol Psychiatry. 2018 Jan;23(1):59-69. doi: 10.1038/mp.2017.190. Epub 2017 Oct 3. Review.

8.

Novel method of altering stimulus parameter to facilitate seizure induction during electroconvulsive therapy.

Thirthalli J, Kumar CN, Mitra S, Ashok AH, Gangadhar BN.

Brain Stimul. 2017 Nov - Dec;10(6):1143-1144. doi: 10.1016/j.brs.2017.08.003. Epub 2017 Aug 7. No abstract available.

PMID:
28807847
9.

Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.

Ashok AH, Mizuno Y, Volkow ND, Howes OD.

JAMA Psychiatry. 2017 May 1;74(5):511-519. doi: 10.1001/jamapsychiatry.2017.0135. Review.

10.

The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment.

Ashok AH, Marques TR, Jauhar S, Nour MM, Goodwin GM, Young AH, Howes OD.

Mol Psychiatry. 2017 May;22(5):666-679. doi: 10.1038/mp.2017.16. Epub 2017 Mar 14. Review.

11.

The effects of Δ9-tetrahydrocannabinol on the dopamine system.

Bloomfield MA, Ashok AH, Volkow ND, Howes OD.

Nature. 2016 Nov 17;539(7629):369-377. doi: 10.1038/nature20153. Review.

12.

Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies.

Ganesh S, Ashok AH, Kumar CN, Thirthalli J.

Asian J Psychiatr. 2016 Aug;22:86-92. doi: 10.1016/j.ajp.2016.05.006. Epub 2016 May 20. Review.

PMID:
27520904
13.

Paul Eugen Bleuler and the origin of the term schizophrenia (SCHIZOPRENIEGRUPPE).

Ashok AH, Baugh J, Yeragani VK.

Indian J Psychiatry. 2012 Jan;54(1):95-6. doi: 10.4103/0019-5545.94660. No abstract available.

Supplemental Content

Loading ...
Support Center